|
NUP153 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.0717000005539E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.47160000033509E-08 |
| Normal-vs-Stage2 |
8.778000E-03 |
| Normal-vs-Stage3 |
2.789000E-01 |
| Normal-vs-Stage4 |
1.698620E-01 |
| Stage1-vs-Stage2 |
4.779400E-01 |
| Stage1-vs-Stage3 |
2.721500E-02 |
| Stage1-vs-Stage4 |
3.295800E-01 |
| Stage2-vs-Stage3 |
3.355200E-01 |
| Stage2-vs-Stage4 |
6.769600E-01 |
| Stage3-vs-Stage4 |
6.897000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.82260000051116E-07 |
| Normal-vs-AfricanAmerican |
2.4362E-05 |
| Normal-vs-Asian |
4.408800E-01 |
| Caucasian-vs-AfricanAmerican |
9.208000E-01 |
| Caucasian-vs-Asian |
5.721800E-01 |
| AfricanAmerican-vs-Asian |
5.117600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.14829999953159E-08 |
| Normal-vs-Female |
1.147800E-01 |
| Male-vs-Female |
1.378020E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.379060E-04 |
| Normal-vs-Extreme_Weight |
2.38160002830057E-09 |
| Normal-vs-Obese |
1.040100E-02 |
| Normal-vs-Extreme_Obese |
5.88519999999981E-05 |
| Normal_Weight-vs-Extreme_Weight |
2.075400E-01 |
| Normal_Weight-vs-Obese |
2.137800E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.723800E-01 |
| Extreme_Weight-vs-Obese |
5.123800E-03 |
| Extreme_Weight-vs-Extreme_Obese |
9.829200E-01 |
| Obese-vs-Extreme_Obese |
1.737230E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.524400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.636740E-04 |
| Normal-vs-Age(61-80Yrs) |
2.11230000157769E-08 |
| Normal-vs-Age(81-100Yrs) |
9.7029000001303E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.546020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.045500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.237920E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.719900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.677600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.187000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.57440000428488E-08 |
| Normal-VS-Type2 PRCC |
6.45739999999284E-05 |
| Normal-VS-KIRP CIMP |
4.714200E-01 |
| Normal-VS-Unclassified PRCC |
2.722100E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.713000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.064000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
7.881600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.034300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
3.393600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.035500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.24989999753467E-08 |
| Normal-vs-N1 |
5.176000E-01 |
| Normal-vs-N2 |
4.381100E-03 |
| N0-vs-N1 |
1.977250E-03 |
| N0-vs-N2 |
9.824800E-01 |
| N1-vs-N2 |
6.680600E-03 |
|
|
